Company logo

CTRE - CareTrust REIT, Inc.

NASDAQ -> Real Estate -> REIT—Healthcare Facilities
San Clemente, United States
Type: Equity

CTRE price evolution
CTRE
(in millions $) 30 Oct 2024 30 Jun 2024 31 Mar 2024 31 Dec 2023
Current assets
Cash $495.13 $451.17 $294.45
Short term investments
Net receivables $0.88 $1.1 $0.4 $0.4
Inventory
Total current assets $411.8 $526.73 $479.32 $318.18
Long term investments
Property, plant & equipment $2489.87 $2139.76 $1852.78 $1747.49
Goodwill & intangible assets
Total noncurrent assets
Total investments
Total assets $2920.88 $2698.75 $2348.44 $2084.84
Current liabilities
Accounts payable $49.72 $37.11 $35.27 $33.99
Deferred revenue
Short long term debt
Total current liabilities $99.44 $81.83 $76.47 $70.52
Long term debt $396.7 $671.15 $595.87 $595.6
Total noncurrent liabilities
Total debt $671.15 $595.87 $595.6
Total liabilities $498.68 $752.98 $672.34 $666.12
Shareholders' equity
Retained earnings -$530.32 -$514.04 -$480.07 -$467.63
Other shareholder equity
Total shareholder equity $1943.69 $1673.8 $1416.82
(in millions $) 31 Dec 2023 31 Jan 2023 31 Dec 2021 31 Dec 2020
Current assets
Cash $294.45 $13.18 $19.89 $18.92
Short term investments
Net receivables $0.4 $0.42 $2.42 $1.82
Inventory
Total current assets $318.18 $25.28 $29.82 $31.2
Long term investments
Property, plant & equipment $1747.49 $1577.78 $1605.13 $1463.1
Goodwill & intangible assets
Total noncurrent assets
Total investments
Total assets $2084.84 $1620.78 $1640.85 $1503.56
Current liabilities
Accounts payable $33.99 $24.36 $25.41 $19.57
Deferred revenue
Short long term debt
Total current liabilities $70.52 $51.91 $51.69 $43.9
Long term debt $595.6 $719.5 $673.4 $545.59
Total noncurrent liabilities
Total debt $595.6 $719.5 $673.4 $545.59
Total liabilities $666.12 $771.41 $725.09 $589.42
Shareholders' equity
Retained earnings -$467.63 -$396.95 -$282.05 -$251.21
Other shareholder equity
Total shareholder equity $1416.82 $849.37 $915.76 $914.14
(in millions $) 30 Oct 2024 30 Jun 2024 31 Mar 2024 31 Dec 2023
Revenue
Total revenue $77.38 $68.89 $63.07 $59.73
Cost of revenue $0.26 $0.66 $0.56
Gross Profit $73.9 $68.64 $62.41 $59.17
Operating activities
Research & development
Selling, general & administrative $6.14 $6.84 $6.51
Total operating expenses $22.79 $21.97 $22.09 $21.45
Operating income $46.66 $40.32 $37.72
Income from continuing operations
EBIT $19.44 $36.97 $34.56
Income tax expense
Interest expense -$6.48 $8.68 $8.23 $8.27
Net income
Net income $33.35 $10.76 $28.75 $26.3
Income (for common shares) $10.76 $28.75 $26.3
(in millions $) 31 Dec 2023 31 Dec 2022 31 Dec 2021 31 Dec 2020
Revenue
Total revenue $217.77 $196.13 $192.35 $178.33
Cost of revenue $3.42 $5.04
Gross Profit $214.35 $191.09 $192.35 $178.33
Operating activities
Research & development
Selling, general & administrative $21.8 $20.16 $26.87 $16.3
Total operating expenses $79.17 $78.66 $85.79 $71.9
Operating income $135.17 $112.44 $106.56 $106.43
Income from continuing operations
EBIT $94.62 $22.5 $95.66 $104.53
Income tax expense
Interest expense $40.88 $30.01 $23.68 $23.66
Net income
Net income $53.73 -$7.51 $71.98 $80.87
Income (for common shares) $53.73 -$7.51 $71.98 $80.87
(in millions $) 30 Oct 2024 30 Jun 2024 31 Mar 2024 31 Dec 2023
Net income $10.76 $28.75 $26.3
Operating activities
Depreciation $13.88 $13.46 $13.23
Business acquisitions & disposals
Stock-based compensation $1.41 $2.12 $1.77
Total cash flows from operations $52.98 $48.82 $42.67
Investing activities
Capital expenditures -$143.83 -$71.12 -$36.77
Investments -$201.66 -$52.16 -$0.59
Total cash flows from investing -$828.09 -$345.4 -$123.24 -$35.51
Financing activities
Dividends paid -$122.44 -$41.19 -$36.53 -$32.4
Sale and purchase of stock $302.45 $269.79 $315.41
Net borrowings $75 -$0.02 -$0.05
Total cash flows from financing $741.7 $336.38 $231.15 $283.8
Effect of exchange rate
Change in cash and equivalents $82.65 $43.96 $156.72 $290.96
(in millions $) 31 Dec 2023 31 Dec 2022 31 Dec 2021 31 Dec 2020
Net income $53.73 -$7.51 $71.98 $80.87
Operating activities
Depreciation $51.26 $50.38 $55.39 $52.82
Business acquisitions & disposals
Stock-based compensation $5.15 $5.76 $10.83 $3.79
Total cash flows from operations $154.77 $144.41 $156.87 $145.74
Investing activities
Capital expenditures -$248.55 -$29.21 -$198.73 -$100.95
Investments -$35.58 -$143.34 -$0.86 $50.43
Total cash flows from investing -$267.81 -$127.4 -$192.63 -$41.58
Financing activities
Dividends paid -$115.49 -$106.14 -$100.78 -$93.16
Sale and purchase of stock $634.45 $47.24 $22.95 -$0.4
Net borrowings -$125.07 $39.64 $115.91 -$10
Total cash flows from financing $394.32 -$23.73 $36.74 -$105.56
Effect of exchange rate
Change in cash and equivalents $281.27 -$6.72 $0.98 -$1.41
Fundamentals
Market cap $4.46B
Enterprise value N/A
Shares outstanding 171.12M
Revenue $269.08M
EBITDA N/A
EBIT N/A
Net Income $99.15M
Revenue Q/Q 38.48%
Revenue Y/Y 28.23%
P/E ratio 45.01
EV/Sales N/A
EV/EBITDA N/A
EV/EBIT N/A
P/S ratio 16.59
P/B ratio N/A
Book/Share N/A
Cash/Share N/A
EPS $0.58
ROA 3.94%
ROE N/A
Debt/Equity 0.47
Net debt/EBITDA N/A
Current ratio 4.14
Quick ratio N/A